84 results
Page 4 of 5
8-K
EX-99.1
8kbdeqy4tbn5oe mo
8 Sep 21
Other Events
4:55pm
8-K
EX-99.2
iuz06q622 njxh
20 Jul 21
Regulation FD Disclosure
8:36am
8-K
EX-99.1
ysfc6t s44
20 Jul 21
Regulation FD Disclosure
8:36am
8-K
EX-99.1
bi0y4ll7z
17 Jun 21
Immunome Appoints Franklyn G. Prendergast, M.D., Ph.D. to Board of Directors
4:55pm
8-K
EX-99.1
d3a 3z7rt8
20 May 21
Immunome Announces Additional $4.3 Million Award by DOD following Positive Preclinical Testing Results on COVID-19 Variants of Concern
9:07am
8-K
EX-99.1
d8pys2
12 May 21
Immunome Reports First Quarter 2021 Financial Results
6:05am
8-K
EX-99.1
hw01y4qf8da4t
26 Apr 21
Regulation FD Disclosure
6:07am
8-K
EX-99.1
v0c9gdz6jxwa lbz
26 Apr 21
Immunome Announces $27 Million Private Placement
6:05am
8-K
EX-99.1
26so9rg6tak8
29 Mar 21
Regulation FD Disclosure
6:02am
8-K
EX-99.1
24zqth5
25 Mar 21
Immunome Reports Fourth Quarter and Full Year 2020 Financial Results, Provides Corporate Update
5:30pm
10-K
hrat3ao ye
25 Mar 21
Annual report
5:01pm
8-K
EX-99.1
6uvll abpznyqd
16 Mar 21
Regulation FD Disclosure
6:00am
8-K
EX-99.1
wt5kngtpcm
17 Nov 20
Immunome Reports Third Quarter 2020 Financial Results and Significant Progress
5:18pm
8-K
EX-99.1
g66wdztblsm8jgihu
26 Oct 20
Regulation FD Disclosure
8:30am
424B4
8jezwtmqnn4joj
5 Oct 20
Prospectus supplement with pricing info
5:10pm
S-1
EX-10.15
ya94vggk3f98rx
9 Sep 20
IPO registration
4:19pm